Pletal

DRUG2 trials

Sponsors

Otsuka America Pharmaceutical

Conditions

Raynaud's Disease

Phase 4

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

CompletedNCT00048776

Otsuka America PharmaceuticalRaynaud's Disease

Start: 2001-10-31End: 2003-06-30Target: 75Updated: 2005-07-19

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

CompletedNCT00048763

Otsuka America PharmaceuticalRaynaud's Disease

Start: 2001-10-31End: 2003-06-30Target: 75Updated: 2005-07-19